1 unchanged sentence
Rule 10b5-1 Trading Plans
−Removed: During the three months ended June 30, 2025, no director or officer of the Company adopted , modified, or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
+Added: During the three months ended September 30, 2025, no director or officer of the Company adopted , modified, or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
12 unchanged sentences
Certificate of Correction to Second Amended and Restated Certificate of Incorporation of The Beauty Health Company
−Removed: 8-K 001-39565 3.1 July 31, 2025
+Added: 8-K 001-39565 3.1 August 1, 2025
Amended and Restated Bylaws of The Beauty Health Company
9 unchanged sentences
Bank Trust Company, National Association, as trustee and collateral agent
+Added: 10-Q 001-39565 4.4 August 7, 2025
Form of Note representing the 7.95% Convertible Senior Secured Notes due 2028 (included as Exhibit A to Exhibit 4.4)
+Added: 10-Q 001-39565 4.5 August 7, 2025
+Added: Supplemental Indenture No.
+Added: 1, dated September 4, 2025, among The Beauty Health Company, the guarantors party thereto and U.S.
+Added: Bank Trust Company, National Association, as trustee and collateral agent
+Added: 8-K 001-39565 4.1 September 4, 2025
Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
10-K 001-39565 4.4 March 12, 2025
−Removed: Form of Exchange Agreement
−Removed: 8-K 001-39565 10.1 May 21, 2025
−Removed: Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
−Removed: Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
+Added: Employment Agreement with Pedro Malha, dated September 29, 2025
+Added: 8-K 001-39565 10.1 September 30, 2025
+Added: Form of Indemnification Agreement (incorporated by reference to Exhibit 10.13 to the Company's Current Report on Form 8-K filed on May 10, 2021)
+Added: 8-K 001-39565 10.2 September 30, 2025
+Added: Separation Agreement, by and between The Beauty Health Company and Marla Beck, dated October 13, 2025
+Added: 8-K 001-39565 10.1 October 17, 2025
EXHIBIT INDEX
1 unchanged sentence
Filed Herewith
+Added: General Release of all Claims, by and between The Beauty Health Company and Marla Beck, dated October 10, 2025
+Added: 8-K 001-39565 10.2 October 17, 2025
+Added: Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
+Added: Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Certification of Principal Executive Officer Pursuant to 18 U.S.C.
17 unchanged sentences
THE BEAUTY HEALTH COMPANY
−Removed: August 7, 2025
−Removed: /s/ Marla Beck
+Added: November 6, 2025
+Added: /s/ Pedro Malha
Chief Executive Officer
(Principal Executive Officer)
−Removed: August 7, 2025
+Added: November 6, 2025
/s/ Michael Monahan
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.